Search for: "TRIBUNE PUBLISHING COMPANY" Results 21 - 40 of 1,792
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Apr 2024, 6:00 pm by Josh Blackman
Article I, Section 8 of the Constitution vests in Congress the authority to "constitute Tribunals inferior to the supreme Court. [read post]
15 Apr 2024, 2:31 am by INFORRM
The AI training practices have raised privacy concerns after some companies used copyrighted material and user data from social media to support AI models. [read post]
12 Apr 2024, 4:00 am by Jim Sedor
Ted Cruz is facing a formal complaint over more than $630,000 sent from the company that syndicates his podcast to a super PAC supporting his reelection bid. [read post]
5 Apr 2024, 6:00 am by Jim Sedor
Trump Media Stock Plunges as 2023 Truth Social Loss Put at $58 Million MSN – Drew Harwell (Washington Post) | Published: 4/1/2024 Donald Trump’s social media company lost more than $58 million last year, sending its stock plunging more than 21 percent only days after a highflying public debut set the company’s value at more than $8 billion. [read post]
28 Mar 2024, 11:48 am by Paul Willetts
That said, even where odds of recovery appear poor, there may nonetheless be a business rationale to pursue the matter – sending a clear message that such behaviour will not be tolerated.A cautionary taleIn March 2024, the BC Civil Resolution Tribunal (the “Tribunal”) dismissed three individual claims brought by a trucking company against former employees seeking damages for time theft. [read post]
22 Mar 2024, 4:00 am by Jim Sedor
Supreme Court seemed prepared to reject a Republican-led effort to sharply limit the federal government from pressuring social media companies to remove harmful posts and misinformation from their platforms. [read post]
15 Mar 2024, 4:00 am by Jim Sedor
But the letter is an example of what transparency advocates say are gaps in the law that allow lawyers and lobbyists, including former officials, to avoid disclosing their advocacy for companies possibly subject to sanctions. [read post]
14 Mar 2024, 5:50 am by Harold Hongju Koh
Private cell phone companies granted universal roaming, and Ukraine’s grid never went down. [read post]
9 Mar 2024, 12:24 am by admin
The Bureau’s market inquiry powers require it to prepare terms of reference for the inquiry, publish the terms of reference, allow the public to provide comments for a minimum of 15 days and publish a final report. [read post]
8 Mar 2024, 3:00 am by Jim Sedor
Trial for April 25 MSN – Ann Marimow (Washington Post) | Published: 3/6/2024 The U.S. [read post]
4 Mar 2024, 1:19 am by INFORRM
The agency said the company did not show why the biometric tracking was necessary. [read post]
2 Mar 2024, 9:18 am by Cristina Mariottini
The second issue of 2023 of Giustizia consensuale (published by Editoriale Scientifica) has just been released, and it features: Giuseppe Trisorio Liuzzi (Professor at the Università degli Studi di Bari “Aldo Moro”), La composizione negoziata. [read post]
1 Mar 2024, 3:00 am by Jim Sedor
Laws That Bar Platforms from Deleting Content MSN – Ann Marimow and Cat Zakrzewski (Washington Post) | Published: 2/26/2024 A majority of the U.S. [read post]
28 Feb 2024, 9:07 am by Zneimer & Zneimer, P.C.
The Chicago Tribune recently published an article with the results of a study they conducted which seem to indicate that Chicago police tend not to issue tickets in pedestrian and cyclist crash cases. [read post]
27 Feb 2024, 4:50 am by David Ashmore and Alison Heaton
Acas also intends to publish non-statutory guidance to sit alongside the Code, although this has not yet been circulated. [read post]
23 Feb 2024, 4:59 pm by Rebecca Tushnet
Limited oversight: fed court worried about undermining confidence in specialized tribunals. [read post]
23 Feb 2024, 12:34 pm by Andrew Vey
Both involve the same British Columbia based insurance company. [read post]
23 Feb 2024, 3:00 am by Jim Sedor
Documents show Juul tried everything from orchestrating untraceable campaign contributions to paying think tanks for favorable research, to revamp its image and prevent both Congress and the FDA from taking action that could cost the company financially. [read post]